As you all know, Carla Funk, the Executive Director of MLA is retiring. So we must search for a new person for the position. I thought I would provide an update on the search for those of you who didn’t see the update published in the September 25 MLA Focus.
The search committee first worked on selecting an executive search firm to help us with the process for filling the position. The search committee sent out several request for proposals (RFPs) to reputable search firms who specialize in the area of finding executive directors for associations. We reviewed the completed and returned proposals and selected Tuft & Associates as our search firm. Tuft & Associates has experience working with other medical and library associations finding executive directors.
Tufts & Associates has been interviewing MLA Board memebers, MLA staff members, and diverse group of MLA members to try and determine the opportunities and challenges for MLA so that they can compile a profile as well as traits desired for the position. Once the profile is complete, the position will be advertised.
MLA members have an opportunity to participate in the process by suggesting questions for candidates. Stay tuned for how to suggestion questions. MLA is looking at away to do compile the suggestions online. The search committee and Tufts anticipate interviews of top candidates will begin in late fall.
The search committee includes Dixie A. Jones, AHIP, chair; Linda Walton; Michelle Kraft, AHIP; Chris Shaffer, AHIP; Sandra G. Franklin, AHIP; and staff member Kate Corcoran.
The diverse group of MLA members were made up of librarians in academic, hospital libraries, living in different areas of the U.S, representing different ages and ethnic backgrounds.
I will write another update when the profile has been completed and the position has been posted. I will also provide more information on how to suggestion questions for the executive director search as soon as the technical details have been worked out.Share on Facebook
This weekend the Toronto Star published a thought-provoking op-ed arguing that in the light of Health Canada's incompetence or outright neglect (summed up pretty well in an editorial published today in the same paper) in failing to demand that Apotex pull tainted or poor quality drugs off their shelves--along with other failures to properly do their job of properly regulating medicines--the actual drug regulatory function of the government body should be reduced or abolished. Instead, writer Amir Attaran argues, we should rely on better-funded, better-toothed foreign drug regulators, as individual countries of the European Union have done, delegating significant aspects of drug regulation to the European Medicines Agency. In our case, that would probably be the American FDA.
What do you think? It's pretty clear that Health Canada has not been the enforcer it's supposed to be. There are a number of reasons for this, including funding as well as the current government's attitude, respectively, to large corporations and scientists/science. Is delegating to a non-Canadian body the solution? Discuss amongst yourselves...Topics: drug safetyhealth canadaregulation